272 related articles for article (PubMed ID: 28056336)
1. The clinical role of circulating free tumor DNA in gastrointestinal malignancy.
Howell JA; Khan SA; Knapp S; Thursz MR; Sharma R
Transl Res; 2017 May; 183():137-154. PubMed ID: 28056336
[TBL] [Abstract][Full Text] [Related]
2. The clinical role of 'liquid biopsy' in hepatocellular carcinoma.
Howell JA; Sharma R
Hepat Oncol; 2016 Jan; 3(1):45-55. PubMed ID: 30191026
[TBL] [Abstract][Full Text] [Related]
3. Circulating tumour DNA (ctDNA) as a liquid biopsy for melanoma.
Calapre L; Warburton L; Millward M; Ziman M; Gray ES
Cancer Lett; 2017 Sep; 404():62-69. PubMed ID: 28687355
[TBL] [Abstract][Full Text] [Related]
4. A Targeted Q-PCR-Based Method for Point Mutation Testing by Analyzing Circulating DNA for Cancer Management Care.
Thierry AR
Methods Mol Biol; 2016; 1392():1-16. PubMed ID: 26843041
[TBL] [Abstract][Full Text] [Related]
5. The feasibility of using mutation detection in ctDNA to assess tumor dynamics.
Yi X; Ma J; Guan Y; Chen R; Yang L; Xia X
Int J Cancer; 2017 Jun; 140(12):2642-2647. PubMed ID: 28124376
[TBL] [Abstract][Full Text] [Related]
6. Use of cell free DNA in breast oncology.
Canzoniero JV; Park BH
Biochim Biophys Acta; 2016 Apr; 1865(2):266-74. PubMed ID: 27012505
[TBL] [Abstract][Full Text] [Related]
7. Monitoring gastric cancer progression with circulating tumour DNA.
Hamakawa T; Kukita Y; Kurokawa Y; Miyazaki Y; Takahashi T; Yamasaki M; Miyata H; Nakajima K; Taniguchi K; Takiguchi S; Mori M; Doki Y; Kato K
Br J Cancer; 2015 Jan; 112(2):352-6. PubMed ID: 25490524
[TBL] [Abstract][Full Text] [Related]
8. Circulating tumour cells and DNA as liquid biopsies in gastrointestinal cancer.
Nordgård O; Tjensvoll K; Gilje B; Søreide K
Br J Surg; 2018 Jan; 105(2):e110-e120. PubMed ID: 29341153
[TBL] [Abstract][Full Text] [Related]
9. Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies.
Nakamura Y; Taniguchi H; Ikeda M; Bando H; Kato K; Morizane C; Esaki T; Komatsu Y; Kawamoto Y; Takahashi N; Ueno M; Kagawa Y; Nishina T; Kato T; Yamamoto Y; Furuse J; Denda T; Kawakami H; Oki E; Nakajima T; Nishida N; Yamaguchi K; Yasui H; Goto M; Matsuhashi N; Ohtsubo K; Yamazaki K; Tsuji A; Okamoto W; Tsuchihara K; Yamanaka T; Miki I; Sakamoto Y; Ichiki H; Hata M; Yamashita R; Ohtsu A; Odegaard JI; Yoshino T
Nat Med; 2020 Dec; 26(12):1859-1864. PubMed ID: 33020649
[TBL] [Abstract][Full Text] [Related]
10. Cell-free DNA for the detection of pancreatic, liver and upper gastrointestinal cancers: has progress been made?
Gall TM; Frampton AE; Krell J; Habib NA; Castellano L; Stebbing J; Jiao LR
Future Oncol; 2013 Dec; 9(12):1861-9. PubMed ID: 24295416
[TBL] [Abstract][Full Text] [Related]
11. Liquid biopsy in non-small cell lung cancer: a key role in the future of personalized medicine?
Pi C; Zhang MF; Peng XX; Zhang YC; Xu CR; Zhou Q
Expert Rev Mol Diagn; 2017 Dec; 17(12):1089-1096. PubMed ID: 29057681
[TBL] [Abstract][Full Text] [Related]
12. Advances in Circulating Tumor DNA Analysis.
Perakis S; Auer M; Belic J; Heitzer E
Adv Clin Chem; 2017; 80():73-153. PubMed ID: 28431643
[TBL] [Abstract][Full Text] [Related]
13. Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer.
Cheng F; Su L; Qian C
Oncotarget; 2016 Jul; 7(30):48832-48841. PubMed ID: 27223063
[TBL] [Abstract][Full Text] [Related]
14. Liquid biopsy: will it be the 'magic tool' for monitoring response of solid tumors to anticancer therapies?
Gingras I; Salgado R; Ignatiadis M
Curr Opin Oncol; 2015 Nov; 27(6):560-7. PubMed ID: 26335664
[TBL] [Abstract][Full Text] [Related]
15. Assessment of circulating copy number variant detection for cancer screening.
Molparia B; Nichani E; Torkamani A
PLoS One; 2017; 12(7):e0180647. PubMed ID: 28686671
[TBL] [Abstract][Full Text] [Related]
16. Circulating Tumor DNA: An Emerging Tool in Gastrointestinal Cancers.
Alese OB; Cook N; Ortega-Franco A; Ulanja MB; Tan L; Tie J
Am Soc Clin Oncol Educ Book; 2022 Apr; 42():1-20. PubMed ID: 35471832
[TBL] [Abstract][Full Text] [Related]
17. Circulating tumor DNA as a liquid biopsy target for detection of pancreatic cancer.
Takai E; Yachida S
World J Gastroenterol; 2016 Oct; 22(38):8480-8488. PubMed ID: 27784960
[TBL] [Abstract][Full Text] [Related]
18. A headlight on liquid biopsies: a challenging tool for breast cancer management.
Massihnia D; Perez A; Bazan V; Bronte G; Castiglia M; Fanale D; Barraco N; Cangemi A; Di Piazza F; Calò V; Rizzo S; Cicero G; Pantuso G; Russo A
Tumour Biol; 2016 Apr; 37(4):4263-73. PubMed ID: 26790442
[TBL] [Abstract][Full Text] [Related]
19. Hybrid Capture-Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Cancers of the Gastrointestinal Tract or Anus.
Schrock AB; Pavlick D; Klempner SJ; Chung JH; Forcier B; Welsh A; Young L; Leyland-Jones B; Bordoni R; Carvajal RD; Chao J; Kurzrock R; Sicklick JK; Ross JS; Stephens PJ; Devoe C; Braiteh F; Ali SM; Miller VA
Clin Cancer Res; 2018 Apr; 24(8):1881-1890. PubMed ID: 29363525
[No Abstract] [Full Text] [Related]
20. Cell-free DNA as a post-treatment surveillance strategy: current status.
Burgener JM; Rostami A; De Carvalho DD; Bratman SV
Semin Oncol; 2017 Oct; 44(5):330-346. PubMed ID: 29580435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]